Research | OneLook Acronym Finder |
Serial Number | 87878589 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Docket Number | S-TMK-032-L |
Law Office Assigned | N80 |
Employee Name | HASFORD, SARAH P |
2018-04-16 | Application Filed |
2018-06-26 | Published for Opposition |
2018-08-21 | Location: INTENT TO USE SECTION |
2019-01-03 | Status: Live/Pending |
2019-01-04 | Transaction Date |
Owner: | Casper Pharma LLC |
Address | 2 Tower Center Blvd, Suite 1101C East Brunswick NJ 08816 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NJ |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | prescription medication for symptomatic relief of anxiety and tension and for the management of pruritus due to allergic conditions |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-04-19 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-23 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2018-05-15 | 3 DOCK D:Assigned to Examiner |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-05-23 | 4 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-06-06 | 5 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2018-06-26 | 6 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-06-26 | 7 NPUB E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-07-30 | 8 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-07-30 | 9 ARAA I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-07-30 | 10 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-07-30 | 11 ARAA I:Incoming Correspondence |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-08-21 | 12 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-01-03 | 13 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2019-01-03 | 14 EXT1 S: |
EXTENSION 1 GRANTED | 2019-01-03 | 15 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-05 | 16 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-06-17 | 17 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2019-06-17 | 18 EXT2 S: |
EXTENSION 2 GRANTED | 2019-06-17 | 19 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-19 | 20 EXRA E:E-Mail |
ASSIGNED TO EXAMINER | 2019-08-16 | 21 DOCK D:Assigned to Examiner |
TEAS EXTENSION RECEIVED | 2019-12-03 | 22 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2019-12-03 | 23 EXT3 S: |
EXTENSION 3 GRANTED | 2019-12-03 | 24 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-05 | 25 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-08-10 | 26 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2020-08-10 | 27 EXT4 S: |
EXTENSION 4 GRANTED | 2020-08-10 | 28 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-08-12 | 29 EXRA E:E-Mail |
ABANDONMENT - NO USE STATEMENT FILED | 2021-03-29 | 30 ABN6 S: |
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-03-29 | 31 MAB6 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.